17:27 IST
BSE
Open Offer
Aspira Pathlab & Diagnostics Open Offer
Promoter group acquired 22.18% stake in Aspira Pathlab via an open offer. This increases their holding to 46%, signaling consolidation of control.
Aspira Pathlab & Diagnostics Ltd
- Share price
- ₹113.25
- Market cap
- ₹116.6 Cr
- Revenue (annual)
- ₹24.98 Cr
- Net profit (annual)
- ₹0.05 Cr
- P/E (TTM)
- -257.6×Sector 53.1×
- Promoter holding
- 46.58%+28.19% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Buying 7Other Announcement 3Open Offer 3Management Change 3Financial Results 3Board Meeting Date 3Promoter Buying (Off-Market) 2Debt & Borrowing 2Annual General Meeting 2Promoter Reclassification 1Fund Raise 1Annual Report 1
Time
3 announcements with these filters
19:39 IST
BSE
Open Offer
Aspira Pathlab & Diagnostics Open Offer: ₹14.72 Cr
Aspira Pathlab & Diagnostics Ltd's Independent Director Committee has recommended an Open Offer for the acquisition of 26,76,180 shares (26% stake) at ₹55 per share. The ₹14.72 Crore offer is led by Mr. Arvind Karsandas Bhanushali and others. The IDC considers the offer fair and reasonable based on SEBI valuation parameters.
- Value
- ₹14.72 Cr
15:43 IST
BSE
Open Offer
Aspira Pathlab & Diagnostics Open Offer: ₹14.72 Cr
Arvind Karsandas Bhanushali and others have launched an open offer to acquire a 26% stake in Aspira Pathlab & Diagnostics Limited at ₹55 per share. The total offer size is ₹14.72 Crore. The tendering period is scheduled from April 15 to April 28, 2026, following a substantial acquisition and change in control.
- Value
- ₹14.72 Cr
- Execution
- Tendering Period: April 15, 2026 to April 28, 2026